| Medical Guidelines | Reason for Update |
|---|---|
| Ablative Techniques for the Myolysis of Uterine Fibroids | Descriptions and policy guidelines updated. Removed FDA information from billing/coding section as FDA status is addressed under Regulatory Status. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Bone Mineral Density Studies | Description and policy guidelines updated. References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to Policy statement. |
| Bronchial Thermoplasty | References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Capsule Endoscopy, Wireless | Description, Regulatory Status and References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Chromoendoscopy as an Adjunct to Colonoscopy | Description, Policy Guidelines and References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Computed Tomography to Detect Coronary Artery Calcification | Policy archived. |
| Confocal Laser Endomicroscopy | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Convection-Enhanced Delivery of Therapeutic Agents to the Brain | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. Reference added. |
| Cord Blood as a Source of Stem Cells | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. References and Regulatory sections updated. Removed referenced medical policy, Hematopoietic Cell Transplantation, from Policy Guidelines and created Related Policy section. |
| Dry Needling of Myofascial Trigger Points | Policy archived. |
| Electrogastrography, Cutaneous | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Electromagnetic Navigation Bronchoscopy | Description, Policy Guidelines, and References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Endobronchial Valves | Description, Policy Guidelines, and References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Enteral Nutrition | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Epidural Steroid Injections for Back Pain | Policy archived. |
| Esophageal pH Monitoring | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Extracorporeal Photopheresis | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. The word “patient” changed to “individual” throughout policy. Regulatory Status section updated. References added. No change to policy statement. |
| Gastric Electrical Stimulation | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Gastroesophageal Reflux Disease, Transendoscopic Therapies | Policy Guidelines and References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Heart-Lung Transplantation | Description updated. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Hematopoietic Cell Transplantation | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. The word “patient” changed to “individual” throughout policy. References added. Policy Guidelines updated without change to policy’s intent. |
| Hormone Pellet Implantation for Treatment of Menopause Related Symptoms | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director Review 3/2026. References updated. No change to policy statement. |
| Infertility Diagnosis and Treatment – B0006 | References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 9/2026. Removed codes 54900, 54901, 55300, 55400, 58970, 58974, 58976, 76948, 89250, 89251, 89253, 89254, 89255, 89258, 89259, 89268, 89272, 89280, 89281, 89290, 89291, 89329, 89335, 89337, 89342, 89343, 89344, 89346, 89352, 89353, 89354, 89356, S4011, S4013, S4014, S4015, S4016, S4017, S4018, S4020, S4021, S4022, S4023, S4025, S4026, S4027, S4028, S4030, S4031, S4037, S4040 from Billing/Coding section. Please refer to the Member's Benefit Booklet for availability of benefits. No change to policy statement. |
| Lung and Lobar Lung Transplantation | Description updated. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Lung Volume Reduction Surgery | Description and Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Maternal and Fetal Diagnostics | References updated. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Meniscal Allografts and Other Meniscal Implants | Policy archived. |
| Monoclonal Antibody Imaging for Prostate Cancer | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. References added. |
| Noninvasive Respiratory Assist Devices | Minor grammar edits made throughout policy. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. Added one Related Policy. References added. |
| Oscillatory Devices for the Treatment of Respiratory Conditions | Updated Description and Regulatory Status. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No changes to policy statement. |
| Ovarian and Internal Iliac Vein Embolization, Ablation and Sclerotherapy | Regulatory status updated. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director Review 3/2026. No change to policy statement. |
| Pancreas Transplant | Description and References sections updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Phrenic Nerve Stimulation for Central Sleep Apnea | References added. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. No changes to policy statement. |
| Polysomnography for Non‒Respiratory Sleep Disorders | Policy archived. |
| Sleep Apnea: Diagnosis and Medical Management | References added. Added the following statement to Billing/Coding section: “Custom fabricated OSA devices should be billed using code E0486.” Specialty Matched Consultant Advisory Panel Review 3/2026. Medical Director Review 3/2026. No change to policy statement. |
| Small Bowel, Small Bowel with Liver, or Multivisceral Transplant | References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Surgery for Femoroacetabular Impingement | Policy archived. |
| Surgery for Obstructive Sleep Apnea and Upper Airway Resistance Syndrome | Policy Guidelines updated. References added. Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. No change to policy statement. |
| Transanal Endoscopic Microsurgery (TEMS) | Policy Guidelines and References updated. Specialty Matched Consultant Advisory Panel 3/2026. Medical Director review 3/2026. |
| Tumor Treatment Fields Therapy | Specialty Matched Consultant Advisory Panel review 3/2026. Medical Director review 3/2026. Added 3 Related Policies. References added. Description, Regulatory Status, and Policy Guidelines sections updated to include FDA indication for non-small cell lung cancer. No change to policy statement. |
| Vertebral Axial Decompression (VAD-X) | Policy archived. |
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2026 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.